<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>VASGEN Ltd &#187; News</title>
	<atom:link href="https://vasgen.co.uk/category/news/feed/" rel="self" type="application/rss+xml" />
	<link>https://vasgen.co.uk</link>
	<description>Innovative ocular and cancer therapeutics</description>
	<lastBuildDate>Fri, 19 Aug 2022 11:19:31 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>VASGEN Wins Therapy Accelerator Funding</title>
		<link>https://vasgen.co.uk/vasgen-wins-therapy-accelerator-funding/</link>
		<comments>https://vasgen.co.uk/vasgen-wins-therapy-accelerator-funding/#comments</comments>
		<pubDate>Fri, 19 Aug 2022 11:16:55 +0000</pubDate>
		<dc:creator>vasgen</dc:creator>
				<category><![CDATA[News]]></category>

		<guid isPermaLink="false">https://vasgen.co.uk/?p=456</guid>
		<description><![CDATA[London UK, 19th  August 2022: Vasgen Limited (“Vasgen” or “the Company”), a speciality biotech company, reports successfully competing in the Hertfordshire Science Partnership...<a href="https://vasgen.co.uk/vasgen-wins-therapy-accelerator-funding/"> <small>Read&#160;more &#187;</small></a>]]></description>
		<wfw:commentRss>https://vasgen.co.uk/vasgen-wins-therapy-accelerator-funding/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>VASGEN Achieves Proof of Concept for Pre-Clinical Ocular R &amp; D Programme-Two Further Patents Granted</title>
		<link>https://vasgen.co.uk/vasgen-achieves-proof-of-concept-for-pre-clinical-ocular-r-d-programme-two-further-patents-granted/</link>
		<comments>https://vasgen.co.uk/vasgen-achieves-proof-of-concept-for-pre-clinical-ocular-r-d-programme-two-further-patents-granted/#comments</comments>
		<pubDate>Mon, 17 Jul 2017 16:31:17 +0000</pubDate>
		<dc:creator>vasgen</dc:creator>
				<category><![CDATA[News]]></category>

		<guid isPermaLink="false">http://vasgen.co.uk/?p=415</guid>
		<description><![CDATA[London UK, 17th July 2017: Vasgen Limited (“Vasgen” or “the Company”), a new speciality biotech company, reports that it has successfully completed proof...<a href="https://vasgen.co.uk/vasgen-achieves-proof-of-concept-for-pre-clinical-ocular-r-d-programme-two-further-patents-granted/"> <small>Read&#160;more &#187;</small></a>]]></description>
		<wfw:commentRss>https://vasgen.co.uk/vasgen-achieves-proof-of-concept-for-pre-clinical-ocular-r-d-programme-two-further-patents-granted/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>VASGEN Shortlisted to Present at Innovate UK Health &amp; Life Science Investment Showcase</title>
		<link>https://vasgen.co.uk/vasgen-shortlisted-to-present-at-innovate-uk-health-life-science-investment-showcase/</link>
		<comments>https://vasgen.co.uk/vasgen-shortlisted-to-present-at-innovate-uk-health-life-science-investment-showcase/#comments</comments>
		<pubDate>Wed, 04 May 2016 17:21:50 +0000</pubDate>
		<dc:creator>vasgen</dc:creator>
				<category><![CDATA[News]]></category>

		<guid isPermaLink="false">http://vasgen.co.uk/?p=405</guid>
		<description><![CDATA[London UK, May 4th 2016: Vasgen Limited (“Vasgen” or “the Company”), a new speciality biotech company, reports that it has been shortlisted to...<a href="https://vasgen.co.uk/vasgen-shortlisted-to-present-at-innovate-uk-health-life-science-investment-showcase/"> <small>Read&#160;more &#187;</small></a>]]></description>
		<wfw:commentRss>https://vasgen.co.uk/vasgen-shortlisted-to-present-at-innovate-uk-health-life-science-investment-showcase/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Vasgen Selected for Mayor of London Delegation to BIO International 2015 (15-18 June 2015)</title>
		<link>https://vasgen.co.uk/vasgen-selected-for-mayor-of-london-delegation-to-bio-international-2015-15-18-june-2015/</link>
		<comments>https://vasgen.co.uk/vasgen-selected-for-mayor-of-london-delegation-to-bio-international-2015-15-18-june-2015/#comments</comments>
		<pubDate>Mon, 01 Jun 2015 20:49:38 +0000</pubDate>
		<dc:creator>vasgen</dc:creator>
				<category><![CDATA[News]]></category>

		<guid isPermaLink="false">http://vasgen.co.uk/?p=396</guid>
		<description><![CDATA[London UK, 1st June 2015: Vasgen Limited (“Vasgen” or “the Company”), a London-based biotech company, reports that it will be attending the BIO...<a href="https://vasgen.co.uk/vasgen-selected-for-mayor-of-london-delegation-to-bio-international-2015-15-18-june-2015/"> <small>Read&#160;more &#187;</small></a>]]></description>
		<wfw:commentRss>https://vasgen.co.uk/vasgen-selected-for-mayor-of-london-delegation-to-bio-international-2015-15-18-june-2015/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Vasgen Receives Grant for US Patent and Advances R&amp;D Operations</title>
		<link>https://vasgen.co.uk/vasgen-receives-grant-for-us-patent-and-advances-rd-operations/</link>
		<comments>https://vasgen.co.uk/vasgen-receives-grant-for-us-patent-and-advances-rd-operations/#comments</comments>
		<pubDate>Tue, 03 Feb 2015 16:55:26 +0000</pubDate>
		<dc:creator>vasgen</dc:creator>
				<category><![CDATA[News]]></category>

		<guid isPermaLink="false">http://vasgen.co.uk/?p=381</guid>
		<description><![CDATA[London UK, 3rd February 2015: Vasgen Limited (“Vasgen” or “the Company”), a new speciality biotech company, reports that the United States Patent and...<a href="https://vasgen.co.uk/vasgen-receives-grant-for-us-patent-and-advances-rd-operations/"> <small>Read&#160;more &#187;</small></a>]]></description>
		<wfw:commentRss>https://vasgen.co.uk/vasgen-receives-grant-for-us-patent-and-advances-rd-operations/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Vasgen Awarded Innovate UK Biomedical Catalyst Feasibility Funding</title>
		<link>https://vasgen.co.uk/vasgen-awarded-innovate-uk-biomedical-catalyst-feasibility-funding/</link>
		<comments>https://vasgen.co.uk/vasgen-awarded-innovate-uk-biomedical-catalyst-feasibility-funding/#comments</comments>
		<pubDate>Tue, 04 Nov 2014 17:06:58 +0000</pubDate>
		<dc:creator>vasgen</dc:creator>
				<category><![CDATA[News]]></category>

		<guid isPermaLink="false">http://vasgen.co.uk/?p=354</guid>
		<description><![CDATA[London UK, 4th November 2014: Vasgen Limited (“Vasgen” or “the Company”), a new speciality biotech company, reports that it has been awarded Biomedical...<a href="https://vasgen.co.uk/vasgen-awarded-innovate-uk-biomedical-catalyst-feasibility-funding/"> <small>Read&#160;more &#187;</small></a>]]></description>
		<wfw:commentRss>https://vasgen.co.uk/vasgen-awarded-innovate-uk-biomedical-catalyst-feasibility-funding/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Vasgen Limited Selected to Participate in Technology Strategy Board Showcase at BioTrinity 2014: 12-14/05/2014</title>
		<link>https://vasgen.co.uk/vasgen-limited-selected-to-participate-in-technology-strategy-board-showcase-at-biotrinity-2014-12-14052014/</link>
		<comments>https://vasgen.co.uk/vasgen-limited-selected-to-participate-in-technology-strategy-board-showcase-at-biotrinity-2014-12-14052014/#comments</comments>
		<pubDate>Mon, 07 Apr 2014 13:56:09 +0000</pubDate>
		<dc:creator>vasgen</dc:creator>
				<category><![CDATA[News]]></category>

		<guid isPermaLink="false">http://vasgen.co.uk/?p=334</guid>
		<description><![CDATA[London UK, 7th April 2014: Vasgen Limited (“Vasgen” or “the Company”), a new speciality biotech company, reports that it has been chosen to...<a href="https://vasgen.co.uk/vasgen-limited-selected-to-participate-in-technology-strategy-board-showcase-at-biotrinity-2014-12-14052014/"> <small>Read&#160;more &#187;</small></a>]]></description>
		<wfw:commentRss>https://vasgen.co.uk/vasgen-limited-selected-to-participate-in-technology-strategy-board-showcase-at-biotrinity-2014-12-14052014/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Vasgen Appoints Oliver Boucher to Board 05/12/13</title>
		<link>https://vasgen.co.uk/vasgen-appoints-oliver-boucher-to-board-051213/</link>
		<comments>https://vasgen.co.uk/vasgen-appoints-oliver-boucher-to-board-051213/#comments</comments>
		<pubDate>Thu, 05 Dec 2013 12:09:05 +0000</pubDate>
		<dc:creator>vasgen</dc:creator>
				<category><![CDATA[News]]></category>

		<guid isPermaLink="false">http://vasgen.co.uk/?p=315</guid>
		<description><![CDATA[London UK, 5th December 2013: Vasgen Limited (“Vasgen” or “the Company”), a new speciality biotech company, reports the appointment of Oliver Boucher to...<a href="https://vasgen.co.uk/vasgen-appoints-oliver-boucher-to-board-051213/"> <small>Read&#160;more &#187;</small></a>]]></description>
		<wfw:commentRss>https://vasgen.co.uk/vasgen-appoints-oliver-boucher-to-board-051213/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Vasgen to Attend 2013 Genesis Conference 12/12/2013</title>
		<link>https://vasgen.co.uk/vasgen-to-attend-2013-genesis-conference-13122012/</link>
		<comments>https://vasgen.co.uk/vasgen-to-attend-2013-genesis-conference-13122012/#comments</comments>
		<pubDate>Thu, 05 Dec 2013 11:47:49 +0000</pubDate>
		<dc:creator>vasgen</dc:creator>
				<category><![CDATA[News]]></category>

		<guid isPermaLink="false">http://vasgen.co.uk/?p=308</guid>
		<description><![CDATA[Vasgen Limited (“Vasgen” or “the Company”), a new speciality biotech company, reports that it will be attending the 2013 Genesis Conference in London...<a href="https://vasgen.co.uk/vasgen-to-attend-2013-genesis-conference-13122012/"> <small>Read&#160;more &#187;</small></a>]]></description>
		<wfw:commentRss>https://vasgen.co.uk/vasgen-to-attend-2013-genesis-conference-13122012/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Vasgen Limited Attends Inaugural ON Helix Conference 09/07/13</title>
		<link>https://vasgen.co.uk/vasgen-limited-attends-inaugural-on-helix-conference-090713/</link>
		<comments>https://vasgen.co.uk/vasgen-limited-attends-inaugural-on-helix-conference-090713/#comments</comments>
		<pubDate>Wed, 10 Jul 2013 17:53:33 +0000</pubDate>
		<dc:creator>vasgen</dc:creator>
				<category><![CDATA[News]]></category>

		<guid isPermaLink="false">http://vasgen.co.uk/?p=303</guid>
		<description><![CDATA[London UK, 10th July 2013: Vasgen Limited (“Vasgen” or “the Company”), a new speciality biotech company, reports its participation at the inaugural ON...<a href="https://vasgen.co.uk/vasgen-limited-attends-inaugural-on-helix-conference-090713/"> <small>Read&#160;more &#187;</small></a>]]></description>
		<wfw:commentRss>https://vasgen.co.uk/vasgen-limited-attends-inaugural-on-helix-conference-090713/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Vasgen Limited to Participate in the Japan – Drug Discovery and Development Event 25/02/2013 &#8211; 01/03/2013</title>
		<link>https://vasgen.co.uk/vasgen-limited-to-participate-in-the-japan-drug-discovery-and-development-event-25022013-01032013/</link>
		<comments>https://vasgen.co.uk/vasgen-limited-to-participate-in-the-japan-drug-discovery-and-development-event-25022013-01032013/#comments</comments>
		<pubDate>Tue, 05 Feb 2013 17:56:35 +0000</pubDate>
		<dc:creator>vasgen</dc:creator>
				<category><![CDATA[News]]></category>

		<guid isPermaLink="false">http://vasgen.co.uk/?p=279</guid>
		<description><![CDATA[Vasgen Limited to Participate in the Japan–Drug Discovery and Development Event 25/02/2013 -01/03/2013 Vasgen Limited (“Vasgen” or “the Company”), a new speciality biotech...<a href="https://vasgen.co.uk/vasgen-limited-to-participate-in-the-japan-drug-discovery-and-development-event-25022013-01032013/"> <small>Read&#160;more &#187;</small></a>]]></description>
		<wfw:commentRss>https://vasgen.co.uk/vasgen-limited-to-participate-in-the-japan-drug-discovery-and-development-event-25022013-01032013/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Vasgen Limited Attends 2012 Genesis Conference 13/12/2012</title>
		<link>https://vasgen.co.uk/vasgen-limited-attends-2012-genesis-conference-13122012/</link>
		<comments>https://vasgen.co.uk/vasgen-limited-attends-2012-genesis-conference-13122012/#comments</comments>
		<pubDate>Mon, 24 Dec 2012 17:31:48 +0000</pubDate>
		<dc:creator>vasgen</dc:creator>
				<category><![CDATA[News]]></category>

		<guid isPermaLink="false">http://vasgen.co.uk/?p=265</guid>
		<description><![CDATA[Vasgen Limited Attends 2012 Genesis Conference 13/12/2012 Vasgen Limited (“Vasgen” or “the Company”), a new speciality biotech company, reports its participation at the...<a href="https://vasgen.co.uk/vasgen-limited-attends-2012-genesis-conference-13122012/"> <small>Read&#160;more &#187;</small></a>]]></description>
		<wfw:commentRss>https://vasgen.co.uk/vasgen-limited-attends-2012-genesis-conference-13122012/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Vasgen Limited Attends 2012 MipTec Conference</title>
		<link>https://vasgen.co.uk/vasgen-limited-attends-2012-miptec-conference/</link>
		<comments>https://vasgen.co.uk/vasgen-limited-attends-2012-miptec-conference/#comments</comments>
		<pubDate>Sun, 28 Oct 2012 08:32:21 +0000</pubDate>
		<dc:creator>vsgn_admin</dc:creator>
				<category><![CDATA[News]]></category>

		<guid isPermaLink="false">http://vasgen.co.uk/?p=228</guid>
		<description><![CDATA[Vasgen Limited (“Vasgen” or “the Company”), a new speciality biotech company, reports its attendance at the MipTec 2012 Conference in Basel, Switzerland. A...<a href="https://vasgen.co.uk/vasgen-limited-attends-2012-miptec-conference/"> <small>Read&#160;more &#187;</small></a>]]></description>
		<wfw:commentRss>https://vasgen.co.uk/vasgen-limited-attends-2012-miptec-conference/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
